Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Market capNo recent closing price
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $343.0K
- −91.4% year over year
- Net income, FY2025
- -$12.8M
- No comparable prior period
- Free cash flow, FY2025
- -$7.04M
- No comparable prior period
- Revenue, Q2 FY2026
- $17.0K
- −89.9% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 7.29K
- Shares sold short
- Change
- +1.89K
- +35.1% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding AWHL, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding AWHL at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Aspira Women's Health Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 (view filing)4:53 PM ET | Jun 5 | 4 days | Schuler Jack W10% Owner | PPurchase | +222.2K | $0.45 | +$100.0K | +5.8%4.05M after | |
| Jun 9, 2026 (view filing)4:53 PM ET | Jun 5 | 4 days | Schuler Jack W10% Owner | PPurchaseCommon Stock, par value $0.001 | +300.0K | $0.00 | $0 | –300.0K after | Derivative |
| May 29, 2026 (view filing)4:05 PM ET | Sep 17, 2025 | 254 days | Fraser John DDirector | PPurchase | +16.4K | $0.45 | +$7.38K | +3.0%566.4K after | Amended |
| May 29, 2026 (view filing)4:05 PM ET | Sep 17, 2025 | 254 days | Fraser John DDirector | PPurchaseCommon Stock, par value $0.001 | +12.3K | $0.00 | $0 | –12.3K after | AmendedDerivative |
| May 29, 2026 (view filing)4:05 PM ET | Sep 17, 2025 | 254 days | cohen Jeffrey kDirector | PPurchase | +55.6K | $0.45 | +$25.0K | +17.4%374.9K after | Amended |
| May 29, 2026 (view filing)4:05 PM ET | Sep 17, 2025 | 254 days | cohen Jeffrey kDirector | PPurchaseCommon Stock, par value $0.001 | +41.7K | $0.00 | $0 | –41.7K after | AmendedDerivative |
| Sep 19, 2025 (view filing)5:26 PM ET | Sep 17 | 2 days | Schuler Jack W10% Owner | PPurchase | +1.11M | $0.45 | +$500.0K | +41.0%3.82M after | |
| Sep 19, 2025 (view filing)5:26 PM ET | Sep 17 | 2 days | Schuler Jack W10% Owner | PPurchaseCommon Stock, par value $0.001 | +833.3K | $0.00 | $0 | –833.3K after | Derivative |
| Mar 10, 2025 (view filing) | Mar 6 | 4 days | Schuler Jack W10% Owner | PPurchase | +800.0K | – | – | – | DerivativePrice outlier |
| Jul 11, 2024 (view filing) | Jul 9 | 2 days | Schuler Jack W10% Owner | PPurchase | +6.54K | – | – | New position6.54K after |
Top 10 13F holders, Q2 2026
View all: Top 10 13F holders, Q2 2026The largest institutional positions in Aspira Women's Health Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding AWHL in 13F filings for Q2 2026.
Holders of 5% or more of AWHL
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Aspira Women's Health Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Schuler Jack W | 13D/A | 8.70%4.05M shares | −0.40 ppfrom 9.10% | Aug 29, 20227 filings | Jun 11, 2026 | SEC |